• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依达肝素与艾加群奈特的非分级中和。

Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa.

机构信息

Cardiovascular Research Institute, 550858Loyola University Chicago, Health Sciences Divisions, Maywood, IL, USA.

Program in Health Science, Universidad Católica de Murcia, Spain.

出版信息

Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221099934. doi: 10.1177/10760296221099934.

DOI:10.1177/10760296221099934
PMID:35535398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9096191/
Abstract

INTRODUCTION

Andexanet alfa (andexanet) is an approved antidote used to reverse the bleeding effects of Direct Oral Anticoagulant (Direct-Xa agents) agents because it reverses anti-Xa activity. Unfractionated heparin (UFH) and low molecular weight heparins (LMWHs) exhibit anti-Xa activity. The purpose is to investigate the neutralization of UFH and LMWH by andexanet in activated clotting time (ACT), thrombelastography (TEG), and anti-Xa due to the protamine sulfate shortage.

METHODS

UFH and LMWH were studied with andexanet, PS, or saline as potential reversal agents/controls at varying concentrations in ACT, TEG, and anti-Xa and compared to each other.

RESULTS

Andexanet partially neutralized both drugs several TEG parameters at high andexanet concentrations, but it was not as effective as protamine sulfate in any of the assays used. Most TEG parameters were correlated with andexanet concentration. In ACT, significant neutralization was demonstrated at many andexanet concentrations for UFH, but not LMWH. UFH was completely neutralized by PS in ACT, while LMWH was partially neutralized by PS in ACT. Andexanet alfa was a less effective neutralization agent than the protamine sulfate as it only partially neutralized UFH in ACT and was ineffective at neutralizing LMWH when tested at the same concentration as PS (10 ug/mL).

CONCLUSION

Andexanet partially neutralized UFH and LMWH with variability between assays, necessitating investigation into assay-dependent differences.

摘要

简介

Andexanet alfa(andexanet)是一种已批准的解毒剂,用于逆转直接口服抗凝剂(Direct-Xa 制剂)的出血作用,因为它逆转了抗-Xa 活性。未分级肝素(UFH)和低分子量肝素(LMWH)具有抗-Xa 活性。目的是研究由于硫酸鱼精蛋白短缺,andexanet 在激活凝血时间(ACT)、血栓弹力图(TEG)和抗-Xa 中对 UFH 和 LMWH 的中和作用。

方法

在 ACT、TEG 和抗-Xa 中,用 andexanet、PS 或生理盐水作为潜在的逆转剂/对照物,研究 UFH 和 LMWH 在不同浓度下的情况,并相互比较。

结果

在高浓度的 andexanet 下,andexanet 部分中和了这两种药物的几种 TEG 参数,但在所有使用的测定中,其效果不如鱼精蛋白硫酸盐。大多数 TEG 参数与 andexanet 浓度相关。在 ACT 中,在许多 andexanet 浓度下,UFH 表现出明显的中和作用,但 LMWH 则不然。UFH 在 ACT 中被 PS 完全中和,而 LMWH 在 ACT 中被 PS 部分中和。在 ACT 中,andexanet 作为一种中和剂的效果不如鱼精蛋白硫酸盐,因为它只能部分中和 UFH,并且在以与 PS(10ug/mL)相同的浓度测试时,对 LMWH 无效。

结论

andexanet 部分中和了 UFH 和 LMWH,不同的测定方法存在差异,需要进一步研究测定方法的差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd85/9096191/09c327061116/10.1177_10760296221099934-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd85/9096191/b35e974c6954/10.1177_10760296221099934-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd85/9096191/0c91007d7fe0/10.1177_10760296221099934-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd85/9096191/e69b4661da9f/10.1177_10760296221099934-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd85/9096191/04f1bdf113ca/10.1177_10760296221099934-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd85/9096191/3bf31b5aaed2/10.1177_10760296221099934-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd85/9096191/cf9b9bcbf447/10.1177_10760296221099934-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd85/9096191/09c327061116/10.1177_10760296221099934-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd85/9096191/b35e974c6954/10.1177_10760296221099934-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd85/9096191/0c91007d7fe0/10.1177_10760296221099934-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd85/9096191/e69b4661da9f/10.1177_10760296221099934-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd85/9096191/04f1bdf113ca/10.1177_10760296221099934-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd85/9096191/3bf31b5aaed2/10.1177_10760296221099934-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd85/9096191/cf9b9bcbf447/10.1177_10760296221099934-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd85/9096191/09c327061116/10.1177_10760296221099934-fig7.jpg

相似文献

1
Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa.依达肝素与艾加群奈特的非分级中和。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221099934. doi: 10.1177/10760296221099934.
2
Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa.基于检测的阿加曲班对未分级肝素、依诺肝素和磺达肝癸钠的中和作用谱的差异。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029619895120. doi: 10.1177/1076029619895120.
3
Andexanet Alfa Neutralizes the Anticoagulant Effects of Unfractionated Heparin of Bovine, Ovine and Porcine Origin Almost as Protamine Sulfate.安多昔单抗几乎能像硫酸鱼精蛋白一样中和牛、羊和猪来源的普通肝素的抗凝作用。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241247558. doi: 10.1177/10760296241247558.
4
Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitors.比较 UHRA、andexanet 和 PER977 对肝素和口服 FXa 抑制剂的逆转活性和作用机制。
Blood Adv. 2018 Aug 28;2(16):2104-2114. doi: 10.1182/bloodadvances.2016003616.
5
In vivo neutralization of unfractionated heparin and low-molecular-weight heparin by a novel salicylamide derivative.新型水杨酰胺衍生物对未分级肝素和低分子量肝素的体内中和作用。
Clin Appl Thromb Hemost. 2010 Aug;16(4):377-86. doi: 10.1177/1076029610366439. Epub 2010 May 11.
6
Novel concatameric heparin-binding peptides reverse heparin and low-molecular-weight heparin anticoagulant activities in patient plasma in vitro and in rats in vivo.新型串联肝素结合肽在体外患者血浆及体内大鼠中可逆转肝素和低分子量肝素的抗凝活性。
Blood. 2004 Feb 15;103(4):1356-63. doi: 10.1182/blood-2003-07-2334. Epub 2003 Oct 23.
7
The effects of unfractionated heparin, low molecular weight heparin and danaparoid on the thromboelastogram (TEG): an in-vitro comparison of standard and heparinase-modified TEGs with conventional coagulation assays.普通肝素、低分子量肝素及达那肝素对血栓弹力图(TEG)的影响:标准及经肝素酶修饰的TEG与传统凝血检测的体外比较
Blood Coagul Fibrinolysis. 2006 Mar;17(2):97-104. doi: 10.1097/01.mbc.0000203859.62739.25.
8
Andexanet alfa-associated heparin resistance in cardiac surgery: mechanism and perspectives.心脏手术中与安多昔单抗相关的肝素抵抗:机制与展望
bioRxiv. 2024 Sep 10:2024.09.09.612152. doi: 10.1101/2024.09.09.612152.
9
Andexanet Alfa, the Possible Alternative to Protamine for Reversal of Unfractionated Heparin.依达赛珠单抗,非肝素类药物逆转普通肝素抗凝作用的可能选择。
Ann Pharmacother. 2021 Feb;55(2):261-264. doi: 10.1177/1060028020943160. Epub 2020 Jul 15.
10
Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro.凝血酶生成试验在体外评估抗凝逆转方面优于传统检测方法。
Thromb Haemost. 2008 Aug;100(2):350-5.

引用本文的文献

1
Andexanet Alfa Neutralizes the Anticoagulant Effects of Unfractionated Heparin of Bovine, Ovine and Porcine Origin Almost as Protamine Sulfate.安多昔单抗几乎能像硫酸鱼精蛋白一样中和牛、羊和猪来源的普通肝素的抗凝作用。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241247558. doi: 10.1177/10760296241247558.
2
Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban by Andexanet Alfa as Measured by Whole Blood Thromboelastographic Analysis.依达赛珠单抗对阿哌沙班、贝曲沙班、依度沙班和利伐沙班的体外中和作用:全血血栓弹力图分析。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221138297. doi: 10.1177/10760296221138297.

本文引用的文献

1
Protamine-The Journey from DNA to Heparin Neutralization to Gene therapy.鱼精蛋白——从 DNA 到肝素中和再到基因治疗的历程。
Semin Thromb Hemost. 2022 Mar;48(2):240-243. doi: 10.1055/s-0041-1736574. Epub 2021 Nov 2.
2
Measuring residual anti-Xa activity of direct factor Xa inhibitors after reversal with andexanet alfa.测定直接因子 Xa 抑制剂在使用andexanet alfa 逆转后的残余抗 Xa 活性。
Int J Lab Hematol. 2021 Aug;43(4):795-801. doi: 10.1111/ijlh.13591. Epub 2021 Jun 5.
3
Protamine Sulfate Neutralization Profile of Various Dosages of Bovine, Ovine and Porcine UFHs and Their Depolymerized Derivatives in Non-Human Primates.
不同剂量牛、羊和猪肝素及其在非人灵长类动物中的解聚衍生物的硫酸鱼精蛋白中和谱。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211005544. doi: 10.1177/10760296211005544.
4
Economic Evaluation of Andexanet Versus Prothrombin Complex Concentrate for Reversal of Factor Xa-Associated Intracranial Hemorrhage.依达赛珠单抗与凝血酶原复合物用于逆转 Xa 因子相关颅内出血的经济学评价。
Stroke. 2021 Apr;52(4):1390-1397. doi: 10.1161/STROKEAHA.120.031108. Epub 2021 Mar 1.
5
Can We Rely on the Activated Clotting Time to Measure Heparin Anticoagulation? A Clinical Evaluation of Two ACT Monitors.我们能否依靠活化凝血时间来测定肝素抗凝效果?两种活化凝血时间监测仪的临床评估。
J Extra Corpor Technol. 2020 Sep;52(3):212-217. doi: 10.1182/ject-2000005.
6
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges.直接口服抗凝药物的应用:常见临床挑战的实用指南。
J Am Heart Assoc. 2020 Jul 7;9(13):e017559. doi: 10.1161/JAHA.120.017559. Epub 2020 Jun 15.
7
Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018.2009-2018 年新药推向市场所需的研发投资估算。
JAMA. 2020 Mar 3;323(9):844-853. doi: 10.1001/jama.2020.1166.
8
Andexanet alfa for reversal of factor Xa inhibitor-associated anticoagulation.安多昔单抗用于逆转Xa因子抑制剂相关的抗凝作用。
Ther Adv Drug Saf. 2019 Nov 26;10:2042098619888133. doi: 10.1177/2042098619888133. eCollection 2019.
9
Difficult Intraoperative Heparinization Following Andexanet Alfa Administration.注射阿哌沙班后术中肝素化困难。
Clin Pract Cases Emerg Med. 2019 Oct 14;3(4):390-394. doi: 10.5811/cpcem.2019.9.43650. eCollection 2019 Nov.
10
Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment Values.Andexanet Alfa 逆转因子 Xa 抑制剂可能会增加血栓形成的风险,与治疗前相比。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619863493. doi: 10.1177/1076029619863493.